Why This Matters for Your Career
Aurobindo Pharma is hiring 6 roles related to this product
SOLRIAMFETOL (solriamfetol) by Aurobindo Pharma is dopamine uptake inhibitors [moa].
Drug data last refreshed 1mo ago
Dopamine Uptake Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Worked on SOLRIAMFETOL at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Aurobindo Pharma is hiring 6 roles related to this product